Clinical trial
A Research Study for Patients With End-Stage Renal Disease (ESRD)
NCT00110890 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00110890 |
|---|---|
| Title | A Research Study for Patients With End-Stage Renal Disease (ESRD) |
| Official title | An Open-Label, Randomised Study Using Cinacalcet to Improve Achievement of Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With ESRD |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | End Stage Renal Disease |
| Intervention type | Drug, Other |
| Interventions | cinacalcet, Standard of care |
| Enrollment | 552 |
| Start date | May 1, 2004 |
| Primary completion | Apr 1, 2005 |
| Completion | Sep 1, 2007 |
| First posted | May 17, 2005 |
| Last update posted | Mar 7, 2011 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: